4,845
Views
20
CrossRef citations to date
0
Altmetric
Psoriasis and atopic dermatitis

Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3

, , , &
Pages 19-26 | Received 10 Apr 2018, Accepted 24 Apr 2018, Published online: 12 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Isabel Belinchón Romero, Esteban Dauden, Carlos Ferrándiz Foraster, Álvaro González-Cantero & Jose Manuel Carrascosa Carrillo. (2022) PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines. Journal of Dermatological Treatment 33:3, pages 1661-1669.
Read now
Mona Shahriari, Ryan W. Harrison, Russel Burge, Chen-Yen Lin, William N. Malatestinic, Orin M. Goldblum, Robert R. McLean, Margaux M. Crabtree, Jacqueline O’Brien, Elsie L. Grace & Mwangi J. Murage. (2022) Disease response and patient-reported outcomes among initiators of ixekizumab. Journal of Dermatological Treatment 33:3, pages 1538-1546.
Read now
Bénédicte Caron, Jean-Yves Jouzeau, Pierre Miossec, Nadine Petitpain, Pierre Gillet, Patrick Netter & Laurent Peyrin-Biroulet. (2022) Gastroenterological safety of IL-17 inhibitors: a systematic literature review. Expert Opinion on Drug Safety 21:2, pages 223-239.
Read now
Sang Woong Youn, Dae Young Yu, Tae Yoon Kim, Byung Soo Kim, Seung Chul Lee, Jeung Hoon Lee, Yong-Beom Choe, Joo-Heung Lee, Jee-Ho Choi, Joo Young Roh, Seong Jin Jo, Eun-So Lee, Min Kyung Shin, Min-Geol Lee, Jingzhi Jiang & YoungJa Lee. (2022) Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator–controlled VOYAGE 1/2 trials. Journal of Dermatological Treatment 33:1, pages 535-541.
Read now
Lluís Puig. (2020) The safety of ixekizumab in psoriasis drug therapy. Expert Opinion on Drug Safety 19:2, pages 117-130.
Read now

Articles from other publishers (15)

Elena Carmona-Rocha & Lluís Puig. (2023) Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium. Immunotherapy.
Crossref
Emilie Sbidian, Anna Chaimani, Robin Guelimi, Ignacio Garcia-Doval, Camille Hua, Carolyn Hughes, Luigi Naldi, Maria Kinberger, Sivem Afach & Laurence Le Cleach. (2023) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2023:7.
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2022) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2022:8.
Crossref
Marloes E. Van Muijen, Sarah E. Thomas, Hans M.M. Groenewoud, Marisol E. Otero, Paul M. Ossenkoppele, Marcellus D. Njoo, Sharon R.P. Dodemont, Else N. Kop, Maartje A.M. Berends, Marjolein I.A. Koetsier, Johannes M. Mommers, John E.M. Körver, Ron A. Tupker, Marjolein S. De Bruin-Weller, Lizelotte J.M.T. Weppner-Parren, Bas Peters, Marloes M. Kleinpenning, Astrid L.A. Kuijpers, W. Peter Arnold, Paula P.M. Van Lümig, Juul M.P.A. Van den Reek & Elke M.G.J. De Jong. (2022) Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort. Acta Dermato-Venereologica 102, pages adv00712.
Crossref
J.M. Carrascosa, L. Puig, I. Belinchón Romero, L. Salgado-Boquete, E. del Alcázar, J.J. Andrés Lencina, D. Moreno & P. de la Cueva. (2022) [Translated article] Practical Update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis with Biologic Therapy. Part 1. Concepts and General Management of Psoriasis With Biologic Therapy. Actas Dermo-Sifiliográficas 113:3, pages T261-T277.
Crossref
J.M. Carrascosa, L. Puig, I. Belinchón Romero, L. Salgado-Boquete, E. del Alcázar, J.J. Andrés Lencina, D. Moreno & P. de la Cueva. (2022) Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 1. «Conceptos y manejo general de la psoriasis con terapia biológica». Actas Dermo-Sifiliográficas 113:3, pages 261-277.
Crossref
Kyle Fahrbach, Grammati Sarri, David M. Phillippo, Binod Neupane, Samantha E. Martel, Sandeep Kiri & Kristian Reich. (2021) Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis. Dermatology and Therapy 11:6, pages 1965-1998.
Crossref
Jason E. Hawkes, Kyoungah See, Russel Burge, Stephanie Strakbein, Missy McKean-Matthews, Daniel Saure, Melinda Gooderham & Craig Leonardi. (2021) Dynamic Visual Representation of Clinical Efficacy of Ixekizumab in Psoriasis. Dermatology and Therapy 11:4, pages 1107-1118.
Crossref
Sang Woong Youn, Dae Young Yu, Byung Soo Kim, Youngdoe Kim, Kwang Joong Kim, Jee‐Ho Choi, Sang Wook Son, Eun‐So Lee, Young Suck Ro, Young Lip Park, YoungJa Lee, Jeung Hoon Lee, Hyun Jeong Park, Tae Yoon Kim, Min‐Geol Lee, Min Kyung Shin, Gwang Seong Choi, Dong Hyun Kim, Seong Jin Jo & Seung Chul Lee. (2021) Clinical outcomes in adult patients with plaque psoriasis treated with ustekinumab under real‐world practice in Korea: A prospective, observational, multi‐center, postmarketing surveillance study. The Journal of Dermatology 48:6, pages 778-785.
Crossref
Natalia KOZAK, Olena BARABANCHYK, Mariia SOBCHENKO, Nataliia MOLOCHEK, Nadiia DOLGAIA, Yuri PENCHUK & Galyna MYKHALCHYSHYN. (2021) Application features of biological therapy in patients with autoimmune diseases. Minerva Biotechnology and Biomolecular Research 33:2.
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2021) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews 2021:12.
Crossref
Benjamin Lockshin, Angel Cronin, Ryan W. Harrison, Robert R. McLean, Laura Anatale‐Tardiff, Russel Burge, Baojin Zhu, William N. Malatestinic, Bilal Atiya, Mwangi J. Murage, Gaia Gallo, Bruce Strober & Abby Van Voorhees. (2021) Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry. Dermatologic Therapy 34:2.
Crossref
Anupam Das, Anand ToshniwalBhushan Madke. (2021) What is new in dermatotherapy?. Indian Journal of Dermatology, Venereology and Leprology 87, pages 135-143.
Crossref
Tiago Torres, Anabela Barcelos, Paulo Filipe & João Eurico Fonseca. (2021) A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains. Frontiers in Medicine 7.
Crossref
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach & Laurence Le Cleach. (2020) Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref